Compare · IMMU vs LMDX
IMMU vs LMDX
Side-by-side comparison of Immunomedics, Inc. (IMMU) and LumiraDx Limited (LMDX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IMMU and LMDX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- LMDX carries a market cap of $2.23B.
- LMDX has more recent analyst coverage (4 ratings vs 0 for IMMU).
- Company
- Immunomedics, Inc.
- LumiraDx Limited
- Price
- -
- $0.02-53.80%
- Market cap
- -
- $2.23B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- n/a
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 4
Latest IMMU
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- NorthStar Appoints Peter Pfreundschuh to Board of Managers
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- SEC Form SC 13G/A filed
- Frequency Therapeutics Appoints Peter Pfreundschuh as Chief Financial Officer
- Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
Latest LMDX
- SEC Form SC 13G/A filed by LumiraDx Limited (Amendment)
- SEC Form SC 13G/A filed by LumiraDx Limited (Amendment)
- SEC Form 6-K filed by LumiraDx Limited
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
- Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- LumiraDx shares are trading lower after the company announced its securities will be suspended from trading on Nasdaq at the open of business tomorrow.
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher
- US Stocks Mixed; Nasdaq Jumps Over 100 Points